Update on Safety Issues in the Treatment of Rheumatic Diseases

Summary

This article provides updates for several commonly used rheumatic disease treatments from the Office of New Drugs, Center for Drug Development and Research, at the United States Food and Drug Administration.

  • Arthritis
  • Rheumatoid Arthritis
  • Rheumatological Autoimmune Disorders
  • Lymphatic Diseases
View Full Text